Skip to main content

Zostavax News

Live Zoster Vaccination Linked to Lower Risk for Cardiovascular Events

THURSDAY, May 8, 2025 – Live zoster vaccination is associated with a lower risk for overall cardiovascular events when compared with no vaccination, according to a study published online May 5 in...

Shingles Vaccine Could Protect Heart Health

WEDNESDAY, May 7, 2025 — The shingles vaccine has benefits that stretch beyond protecting older adults from the painful skin condition, a new study says. Folks who get the shingles jab have a 23% l...

Zoster Vaccine Has Dementia-Preventing or Delaying Effect

THURSDAY, April 3, 2025 – Zoster vaccination seems to have a dementia-preventing or dementia-delaying effect, according to a study published online April 2 in Nature. Markus Eyting, Ph.D., from...

Shingles Vaccine Protects Against Dementia

TUESDAY, April 2, 2025 – The shingles vaccine can do more than protect seniors from painful, blistering rashes. It also appears to protect older folks from dementia, researchers say. Seniors who got...

CureVac’s Coronavirus Vaccine at the Center of a Fight for Control

CureVac, a German biopharmaceutical company, has hit the headlines after US President Trump tried to secure exclusive rights to its developmental coronavirus vaccine. The vaccine is being developed...

Shingrix (zoster vaccine recombinant, adjuvanted) Approved in the U.S. for Prevention of Shingles

London UK 20 October 2017 – GlaxoSmithKline plc [LSE/NYSE: GSK] today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Zostavax patient information at Drugs.com